RT Journal Article
SR Electronic
T1 Predicting Current Juul use among Emerging Adults through Twitter Feeds
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19010553
DO 10.1101/19010553
A1 Tran, Tung
A1 Ickes, Melinda
A1 Hester, Jakob W.
A1 Kavuluru, Ramakanth
YR 2019
UL http://medrxiv.org/content/early/2019/11/02/19010553.abstract
AB Introduction Can we predict whether someone uses Juul based on their social media activities? This is the central premise of the effort reported in this paper. Several recent social media-related studies on Juul use tend to focus on the characterization of Juul-related messages on social media. In this study, we assess the potential in using machine learning methods to automatically identify whether an individual uses Juul (past 30-day usage) based on their Twitter data.Methods We obtained a collection of 588 instances, for training and testing, of Juul use patterns (along with associated Twitter handles) via survey responses of college students. With this data, we built and tested supervised machine learning models based on linear and deep learning algorithms with textual, social network (friends and followers), and other hand-crafted features.Results The linear model with textual and follower network features performed best with a precision-recall trade-off such that precision (PPV) is 57% at 24% recall (sensitivity). Hence, at least every other college-attending Twitter user flagged by our model is expected to be a Juul user. Additionally, our results indicate that social network features tend to have a large impact (positive) on predictive performance.Conclusion There are enough predictive signals from social feeds for supervised modeling of Juul use, even with limited training data, implying that such models are highly beneficial to very focused intervention campaigns. Moreover, this initial success indicates potential for more involved automated surveillance of Juul use based on social media data, including Juul usage patterns, nicotine dependency, and risk awareness.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the U.S. National Cancer Institute through NIH grant R21CA218231. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNot applicable